Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioGenes
Berlin, Germany
- Ownership
- Private
- Employees
- ~65
- Development stage
- Other
01
Overview
BioGenes is a leading service provider in customized immunoassays and antibody development, supporting analytical and quality control needs in biologics development and production for major pharma, biotech, and CMOs; programs are client-driven, with applications in vaccines and biopharmaceuticals across preclinical to clinical stages.[1][2][5]
- Modalities
- AntibodyImmunoassayProtein
- Industry
- Drug Discovery Services
02
Partnerships
Rentschler BiopharmaBühlmann LaboratoriesSolvias AGElevaADC TherapeuticsFormyconMorphoSysIdorsia Pharmaceuticals
Beyond the preview
Go deeper on BioGenes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioGenes.